These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3168163)
21. DNA adduct formation and removal in hepatic chromatin fractions from rats chronically fed 2-acetylaminofluorene. Poirier MC; Fullerton NF; Patterson ED; Beland FA Carcinogenesis; 1990 Aug; 11(8):1343-7. PubMed ID: 2387020 [TBL] [Abstract][Full Text] [Related]
22. Monitoring carcinogen actions on DNA by 32P-postlabeling. Randerath K; Randerath E Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685 [TBL] [Abstract][Full Text] [Related]
23. Formation and removal of (guan-8-yl)-DNA-2-acetylaminofluorene adducts in liver and kidney of male rats given dietary 2-acetylaminofluorene. Poirier MC; True B; Laishes BA Cancer Res; 1982 Apr; 42(4):1317-21. PubMed ID: 7060010 [TBL] [Abstract][Full Text] [Related]
24. Rapid decreases in indigenous covalent DNA modifications (I-compounds) of male Fischer-344 rat liver DNA by diquat treatment. Vulimiri SV; Gupta S; Smith CV; Moorthy B; Randerath K Chem Biol Interact; 1995 Mar; 95(1-2):1-16. PubMed ID: 7697743 [TBL] [Abstract][Full Text] [Related]
25. Biphasic removal of DNA adducts in a repetitive DNA sequence after dietary administration of 2-acetylaminofluorene. Culp SJ; Poirier MC; Beland FA Environ Health Perspect; 1993 Mar; 99():273-5. PubMed ID: 8319642 [TBL] [Abstract][Full Text] [Related]
26. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method. Gorelick NJ; Wogan GN Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301 [TBL] [Abstract][Full Text] [Related]
27. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts. Reddy MV Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535 [TBL] [Abstract][Full Text] [Related]
28. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl. van de Poll ML; van der Hulst DA; Tates AD; Meerman JH Carcinogenesis; 1990 Feb; 11(2):333-9. PubMed ID: 2302760 [TBL] [Abstract][Full Text] [Related]
29. Effects of carcinogen treatment on rat liver DNA synthesis in vivo and on nascent DNA synthesis and elongation in cultured hepatocytes. Zurlo J; Eustice DC; Mignano JE; Poirier MC; Yager JD Mutat Res; 1986 Jul; 161(2):143-54. PubMed ID: 3724770 [TBL] [Abstract][Full Text] [Related]
30. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Reddy MV; Randerath K Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601 [TBL] [Abstract][Full Text] [Related]
31. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122 [TBL] [Abstract][Full Text] [Related]
32. Age-dependent covalent DNA alterations (I-compounds) in rat liver mitochondrial DNA. Gupta KP; van Golen KL; Randerath E; Randerath K Mutat Res; 1990 Jan; 237(1):17-27. PubMed ID: 2320036 [TBL] [Abstract][Full Text] [Related]
33. Dose-related differences in DNA adduct levels in rodent tissues following skin application of complex mixtures from air pollution sources. Gallagher JE; Jackson MA; George MH; Lewtas J Carcinogenesis; 1990 Jan; 11(1):63-8. PubMed ID: 2403860 [TBL] [Abstract][Full Text] [Related]
34. Use of 2-acetamidophenanthrene and 2-acetamidofluorene in investigations of mechanisms of hepatocarcinogenesis. Scribner JD; Woodworth B; Koponen G; Holmes EH Environ Health Perspect; 1983 Mar; 49():81-6. PubMed ID: 6832098 [TBL] [Abstract][Full Text] [Related]
35. Sex differences in DNA damage produced by the carcinogen 2-acetylaminofluorene in cultured human hepatocytes compared to rat liver and cultured rat hepatocytes. Williams GM; Duan JD; Iatropoulos MJ; Perrone CE Arch Toxicol; 2016 Feb; 90(2):427-32. PubMed ID: 25510676 [TBL] [Abstract][Full Text] [Related]
36. DNA adduct formation and removal in specific liver cell populations during chronic dietary administration of 2-acetylaminofluorene. Poirier MC; Beland FA; Deal FH; Swenberg JA Carcinogenesis; 1989 Jun; 10(6):1143-5. PubMed ID: 2720908 [TBL] [Abstract][Full Text] [Related]
37. The organ-specific induction of DNA adducts in 2-acetylaminofluorene-treated rats, studied by means of a sensitive immunochemical method. Baan RA; Lansbergen MJ; de Bruin PA; Willems MI; Lohman PH Mutat Res; 1985; 150(1-2):23-32. PubMed ID: 4000159 [TBL] [Abstract][Full Text] [Related]
38. 32P analysis of DNA adducts in tissues of benzene-treated rats. Reddy MV; Blackburn GR; Schreiner CA; Mehlman MA; Mackerer CR Environ Health Perspect; 1989 Jul; 82():253-7. PubMed ID: 2792046 [TBL] [Abstract][Full Text] [Related]
39. Species and tissue specificities of I-compounds as contrasted with carcinogen adducts in liver, kidney and skin DNA of Sprague-Dawley rats, ICR mice and Syrian hamsters. Li DH; Xu DC; Randerath K Carcinogenesis; 1990 Dec; 11(12):2227-32. PubMed ID: 2124953 [TBL] [Abstract][Full Text] [Related]
40. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis. Randerath K; Liehr JG; Gladek A; Randerath E IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]